Thursday, September 17

Browsing: malignant

Research

N6-methyladenosine–mediated up-regulation of ARRB2 regulates intrahepatic cholangiocarcinoma malignant progression and pemigatinib resistance through MAPK and Hippo signaling pathways

By NewsCancerApril 15, 20260

Brindley PJ, Bachini M, Ilyas SI, Khan SA, Loukas A, Sirica AE, et al. Cholangiocarcinoma. Nat Rev Dis Primers. 2021;7:65.…

Support

FDA Grants ODD to Rhenium-186 Obisbemeda for Pediatric Malignant Glioma

By NewsCancerApril 9, 20260

The FDA has granted orphan drug designation to rhenium-186 obisbemeda (Reyobiq; 186RNL) for the treatment of patients with pediatric malignant…

Survivors

FDA Grants Orphan Drug Status to Irinotecan-ChemoSeed for Malignant Glioma

By NewsCancerMarch 18, 20260

The FDA has granted orphan drug designation to irinotecan for the treatment of malignant gliomas, expanding beyond the original designation…

Research

Restoring the tumour mechanophenotype of vocal fold cancer reverts its malignant properties

By NewsCancerFebruary 20, 20260

Ethical considerationsUse of animals: we confirm that our research complies with all relevant ethical regulations. Mouse intratongue injection was ethically…